• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; SPINAL CORD STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; SPINAL CORD STIMULATOR Back to Search Results
Model Number 71005
Device Problem Migration (4003)
Patient Problem Inadequate Pain Relief (2388)
Event Date 01/25/2024
Event Type  Injury  
Manufacturer Narrative
There are no indications of any device or component failure or malfunction, as evidenced by all components remaining in use.Intra-op testing was conducted during the initial implant procedure and returned good results and complaints of communication issues were received several months after the implant, thus seeming to indicate that the initial placement of the device was appropriate.There are no reports of any external trauma, strenuous activity, or significant weight changes that would likely lead to the symptoms experienced.Any imaging performed prior to the revision has not been made available to the firm for review to confirm depth and placement of the implanted components.Most likely cause of the communication issues is migration of the ipg, which is a known inherent risk of implantable neuromodulation systems.
 
Event Description
Patient was implanted with the nalu spinal cord stimulator system on (b)(6) 2022 to treat back pain.In (b)(6) 2023 the patient reported issues maintaining communication between the implantable pulse generator (ipg) and the external therapy discs, causing loss of therapy and inadequate pain relief.Reprogramming and troubleshooting was performed on (b)(6) 2023 and noted that the communication issues were exacerbated with specific movements by the patient.Troubleshooting appeared to resolve the issue at the time, however the firm was notified on (b)(6) 2024 that the patient was scheduled for surgical revision due to ongoing communication issues.On (b)(6) 2024 a surgical procedure was performed to move the existing ipg to a more optimal position.No components were explanted or replaced during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
SPINAL CORD STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008 2377
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
rebecca hess
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key18774937
MDR Text Key336175916
Report Number3015425075-2024-00063
Device Sequence Number1
Product Code GZB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/03/2023
Device Model Number71005
Device Catalogue Number71005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/25/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-